190 related articles for article (PubMed ID: 19416203)
1. Reversal of cardiac fibrosis and related dysfunction by relaxin.
Du XJ; Xu Q; Lekgabe E; Gao XM; Kiriazis H; Moore XL; Dart AM; Tregear GW; Bathgate RA; Samuel CS
Ann N Y Acad Sci; 2009 Apr; 1160():278-84. PubMed ID: 19416203
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated delivery of relaxin reverses cardiac fibrosis.
Bathgate RA; Lekgabe ED; McGuane JT; Su Y; Pham T; Ferraro T; Layfield S; Hannan RD; Thomas WG; Samuel CS; Du XJ
Mol Cell Endocrinol; 2008 Jan; 280(1-2):30-8. PubMed ID: 17961912
[TBL] [Abstract][Full Text] [Related]
3. Relaxin: an endogenous renoprotective factor?
Hewitson TD; Samuel CS
Ann N Y Acad Sci; 2009 Apr; 1160():289-93. PubMed ID: 19416206
[TBL] [Abstract][Full Text] [Related]
4. Improved chemical synthesis and demonstration of the relaxin receptor binding affinity and biological activity of mouse relaxin.
Samuel CS; Lin F; Hossain MA; Zhao C; Ferraro T; Bathgate RA; Tregear GW; Wade JD
Biochemistry; 2007 May; 46(18):5374-81. PubMed ID: 17425335
[TBL] [Abstract][Full Text] [Related]
5. Relaxin in cardiovascular and renal disease.
Samuel CS; Hewitson TD
Kidney Int; 2006 May; 69(9):1498-502. PubMed ID: 16672919
[TBL] [Abstract][Full Text] [Related]
6. Basic progress and future therapeutic perspectives of relaxin in ischemic heart disease.
Bani D; Nistri S; Sacchi TB; Bigazzi M
Ann N Y Acad Sci; 2005 May; 1041():423-30. PubMed ID: 15956740
[TBL] [Abstract][Full Text] [Related]
7. 'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease.
Samuel CS; Du XJ; Bathgate RA; Summers RJ
Pharmacol Ther; 2006 Nov; 112(2):529-52. PubMed ID: 16814863
[TBL] [Abstract][Full Text] [Related]
8. Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis.
Samuel CS; Zhao C; Bathgate RA; Bond CP; Burton MD; Parry LJ; Summers RJ; Tang ML; Amento EP; Tregear GW
FASEB J; 2003 Jan; 17(1):121-3. PubMed ID: 12424226
[TBL] [Abstract][Full Text] [Related]
9. Relaxin inhibit cardiac fibrosis induced by phorbol 12-myristate 13-acetate.
Wang YP; Wang P; Dong L; Chen H; Wu YQ; Li HW; Li M
Biomed Environ Sci; 2014 Feb; 27(2):138-41. PubMed ID: 24625407
[TBL] [Abstract][Full Text] [Related]
10. Relaxin regulates collagen overproduction associated with experimental progressive renal fibrosis.
Samuel CS; Mookerjee I; Masterson R; Tregear GW; Hewitson TD
Ann N Y Acad Sci; 2005 May; 1041():182-4. PubMed ID: 15956704
[TBL] [Abstract][Full Text] [Related]
11. Role of relaxin in regulation of fibrosis in the lung.
Tang ML; Samuel CS; Royce SG
Ann N Y Acad Sci; 2009 Apr; 1160():342-7. PubMed ID: 19416216
[TBL] [Abstract][Full Text] [Related]
12. Mast cell inhibition and reduced ventricular arrhythmias in a swine model of acute myocardial infarction upon therapeutic administration of relaxin.
Nistri S; Cinci L; Perna AM; Masini E; Bani D
Inflamm Res; 2008; 57 Suppl 1():S7-8. PubMed ID: 18345514
[No Abstract] [Full Text] [Related]
13. Relaxin and the progression of kidney disease.
Samuel CS; Hewitson TD
Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):9-14. PubMed ID: 19077683
[TBL] [Abstract][Full Text] [Related]
14. Relaxin family peptide receptors--from orphans to therapeutic targets.
van der Westhuizen ET; Halls ML; Samuel CS; Bathgate RA; Unemori EN; Sutton SW; Summers RJ
Drug Discov Today; 2008 Aug; 13(15-16):640-51. PubMed ID: 18675759
[TBL] [Abstract][Full Text] [Related]
15. Relaxin and the extracellular matrix: molecular mechanisms of action and implications for cardiovascular disease.
McGuane JT; Parry LJ
Expert Rev Mol Med; 2005 Sep; 7(21):1-18. PubMed ID: 16191259
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of relaxin's antifibrotic action by SELDI-TOF mass spectrometry-based profiling of relaxin knockout mice, a model of progressive fibrosis.
Giannakis E; Macris M; Chan L; Tregear GW; Samuel CS; Wade JD
Ann N Y Acad Sci; 2009 Apr; 1160():350-2. PubMed ID: 19416218
[TBL] [Abstract][Full Text] [Related]
17. The use of relaxin improves healing in injured muscle.
Li Y; Negishi S; Sakamoto M; Usas A; Huard J
Ann N Y Acad Sci; 2005 May; 1041():395-7. PubMed ID: 15956737
[TBL] [Abstract][Full Text] [Related]
18. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.
Popov Y; Schuppan D
Hepatology; 2009 Oct; 50(4):1294-306. PubMed ID: 19711424
[TBL] [Abstract][Full Text] [Related]
19. Prominent role of relaxin in improving postinfarction heart remodeling.
Bani D; Nistri S; Formigli L; Meacci E; Francini F; Zecchi-Orlandini S
Ann N Y Acad Sci; 2009 Apr; 1160():269-77. PubMed ID: 19416202
[TBL] [Abstract][Full Text] [Related]
20. Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failure.
Verdino P; Lee SL; Cooper FN; Cottle SR; Grealish PF; Hu CC; Meyer CM; Lin J; Copeland V; Porter G; Schroeder RL; Thompson TD; Porras LL; Dey A; Zhang HY; Beebe EC; Matkovich SJ; Coskun T; Balciunas AM; Ferrante A; Siegel R; Malherbe L; Bivi N; Paavola CD; Hansen RJ; Abernathy MM; Nwosu SO; Carr MC; Heuer JG; Wang X
Br J Pharmacol; 2023 Aug; 180(15):1965-1980. PubMed ID: 36780899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
